bpc 157 degenerative disc disease Stable Gastric Pentadecapeptide 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions BPC-157: What It Is, What
Description
There are no active IND applications or FDA-registered human clinical trials for BPC-157
Individuals with significant liver disease, kidney disease, active cancer, or complex medical conditions should discuss potential risks and benefits with their healthcare team before considering compounded peptide therapy
Cold peptide solution causes more discomfort at the injection site and can lead to increased local reactions
If you compete in a WADA-governed sport or any organization that follows WADAs prohibited list including many collegiate and professional leagues using BPC-157 could result in a doping violation
